{"schema_version":"secwatch.filing_event.v1","accession":"0001372514-23-000112","form_type":"8-K","ticker":"KPRX","cik":"0001372514","company_name":"KIORA PHARMACEUTICALS INC","filed_at":"2023-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.729442+00:00","generated_at":"2026-06-12T17:31:07.594114+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Kiora Pharmaceuticals appoints Carmine Stengone to Board of Directors","bullets":["Carmine Stengone (President & CEO of Pipeline Therapeutics) appointed as independent Class I director; term to 2025 annual meeting.","Stengone raised >$180M and executed a >$1B collaboration with Janssen; expertise in small molecules and neurodegenerative diseases.","He will advise on strategic decisions and clinical development, notably for KIO-301 (retinitis pigmentosa candidate in ABACUS trial).","Board determined independence under Nasdaq rules; compensation same as other non-employee directors.","No arrangements, family relationships, or material transactions with the company since start of last fiscal year."],"urls":{"canonical":"https://secwatch.observer/filing/0001372514-23-000112","json":"https://secwatch.observer/filing/0001372514-23-000112.json","markdown":"https://secwatch.observer/filing/0001372514-23-000112.md","text":"https://secwatch.observer/filing/0001372514-23-000112.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000112/0001372514-23-000112-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000112/kprx-20230801.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T17:31:07.594114+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e5f10c7640","claim":"Carmine Stengone was appointed as Director at KIORA PHARMACEUTICALS INC.","evidence_excerpt":"On August 1, 2023, the Board of Directors (the “Board”) of Kiora Pharmaceuticals, Inc. (the “Company”) appointed Carmine Stengone as a member of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000112/0001372514-23-000112-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}